5 pharmaceuticals, namely, polypeptides, particularly antibodies and antibody derivatives, for use in the treatment of tumorous diseases, allergies, autoimmunity, inflammation, infectious diseases, osteoporosis, graft versus host diseases, transplant rejection, coronary heart diseases, B-cell disorders, and minimal residual diseases, in the form of intravenous, sub-cutaneous, intraperitoneal, intra-muscular and aerosol therapies